A percutaneous coronary intervention lab in every hospital?

PubWeight™: 1.63‹?› | Rank: Top 4%

🔗 View Article (PMC 4440579)

Published in Circ Cardiovasc Qual Outcomes on December 06, 2011

Authors

Thomas W Concannon1, Jason Nelson, Jessica Goetz, John L Griffith

Author Affiliations

1: Institute for Clinical Research and Health Policy Studies, Tufts Medical Center and Tufts University School of Medicine, Boston, MA 02111, USA. tconcannon@tuftsmedicalcenter.org

Articles cited by this

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet (2003) 19.90

Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med (1985) 5.09

Access to trauma centers in the United States. JAMA (2005) 3.70

Coronary revascularization trends in the United States, 2001-2008. JAMA (2011) 2.81

A meta-analysis of prehospital care times for trauma. Prehosp Emerg Care (2006) 2.80

Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am J Cardiol (2003) 2.55

Driving times and distances to hospitals with percutaneous coronary intervention in the United States: implications for prehospital triage of patients with ST-elevation myocardial infarction. Circulation (2006) 2.40

Regionalization of care for acute ischemic heart disease: a call for specialized centers. Circulation (2003) 2.35

Weekly variation of acute myocardial infarction. Increased Monday risk in the working population. Circulation (1994) 2.02

Development of systems of care for ST-elevation myocardial infarction patients: executive summary. Circulation (2007) 1.85

Primary percutaneous coronary intervention expansion to hospitals without on-site cardiac surgery in Michigan: a geographic information systems analysis. Am Heart J (2008) 1.65

Balancing the benefits of primary angioplasty against the benefits of thrombolytic therapy for acute myocardial infarction: the importance of timing. Eff Clin Pract (2001) 1.57

Income, insurance, and technology: why does health spending outpace economic growth? Health Aff (Millwood) (2009) 1.44

Recommendation to develop strategies to increase the number of ST-segment-elevation myocardial infarction patients with timely access to primary percutaneous coronary intervention. Circulation (2006) 1.39

Access to pediatric trauma care in the United States. Arch Pediatr Adolesc Med (2009) 1.36

Comparative effectiveness of ST-segment-elevation myocardial infarction regionalization strategies. Circ Cardiovasc Qual Outcomes (2010) 1.28

Geographic access to burn center hospitals. JAMA (2009) 1.10

Evaluating and improving the quality of care for acute myocardial infarction: can regionalization help? JAMA (2006) 0.99

A geospatial analysis of emergency transport and inter-hospital transfer in ST-segment elevation myocardial infarction. Am J Cardiol (2007) 0.97

New cardiac surgery programs established from 1993 to 2004 led to little increased access, substantial duplication of services. Health Aff (Millwood) (2011) 0.96

2004 American College of Cardiology/American Heart Association guidelines for the management of patients with ST-elevation myocardial infarction: implications for emergency department practice. Ann Emerg Med (2005) 0.91

Regionalized care for patients with ST-elevation myocardial infarction: it's closer than you think. Circulation (2006) 0.85

Articles by these authors

Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA (2005) 9.61

Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol (2004) 8.21

Profiling care provided by different groups of physicians: effects of patient case-mix (bias) and physician-level clustering on quality assessment results. Ann Intern Med (2002) 4.24

Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia: a randomized controlled trial. JAMA (2002) 3.65

Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol (2003) 3.48

Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial. JAMA (2012) 3.41

Parental perspectives on end-of-life care in the pediatric intensive care unit. Crit Care Med (2002) 2.81

Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int (2003) 2.77

Uric acid and incident kidney disease in the community. J Am Soc Nephrol (2008) 2.44

An independently derived and validated predictive model for selecting patients with myocardial infarction who are likely to benefit from tissue plasminogen activator compared with streptokinase. Am J Med (2002) 2.12

Predicting mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry. Am J Kidney Dis (2011) 2.01

The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol (2007) 2.00

The Boston Puerto Rican Health Study, a longitudinal cohort study on health disparities in Puerto Rican adults: challenges and opportunities. BMC Public Health (2010) 1.93

Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis (2008) 1.92

Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders. Am J Kidney Dis (2008) 1.91

Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis (2004) 1.88

Elapsed time in emergency medical services for patients with cardiac complaints: are some patients at greater risk for delay? Circ Cardiovasc Qual Outcomes (2009) 1.71

Evidence of systematic duplication by new percutaneous coronary intervention programs. Circ Cardiovasc Qual Outcomes (2013) 1.66

The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD. Am J Kidney Dis (2008) 1.53

Use of the electrocardiograph-based thrombolytic predictive instrument to assist thrombolytic and reperfusion therapy for acute myocardial infarction. A multicenter, randomized, controlled, clinical effectiveness trial. Ann Intern Med (2002) 1.49

A new taxonomy for stakeholder engagement in patient-centered outcomes research. J Gen Intern Med (2012) 1.47

Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the Diabetes Prevention Program. Diabetes Care (2012) 1.42

External validity of predictive models: a comparison of logistic regression, classification trees, and neural networks. J Clin Epidemiol (2003) 1.35

Improving the reliability of physician performance assessment: identifying the "physician effect" on quality and creating composite measures. Med Care (2009) 1.29

Comparative effectiveness of ST-segment-elevation myocardial infarction regionalization strategies. Circ Cardiovasc Qual Outcomes (2010) 1.28

Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. J Am Soc Nephrol (2005) 1.28

Relationship of HIV viral loads, CD4 counts, and HAART use to health-related quality of life. J Acquir Immune Defic Syndr (2002) 1.26

Lowest systolic blood pressure is associated with stroke in stages 3 to 4 chronic kidney disease. J Am Soc Nephrol (2007) 1.25

Depression and cognitive function in maintenance hemodialysis patients. Am J Kidney Dis (2010) 1.24

Study design for the Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care (IMMEDIATE) Trial: A double-blind randomized controlled trial of intravenous glucose, insulin, and potassium for acute coronary syndromes in emergency medical services. Am Heart J (2012) 1.15

Random treatment assignment using mathematical equipoise for comparative effectiveness trials. Clin Transl Sci (2011) 1.14

Geographic access to burn center hospitals. JAMA (2009) 1.10

Kidney disease, Framingham risk scores, and cardiac and mortality outcomes. Am J Med (2007) 1.08

Effect of bone mineral guideline target achievement on mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry. Am J Kidney Dis (2010) 1.05

Smoking cessation in primary care: a clinical effectiveness trial of two simple interventions. Prev Med (2004) 1.05

Emergency medical service predictive instrument-aided diagnosis and treatment of acute coronary syndromes and ST-segment elevation myocardial infarction in the IMMEDIATE trial. Prehosp Emerg Care (2011) 1.05

Comparison of mortality benefit of immediate thrombolytic therapy versus delayed primary angioplasty for acute myocardial infarction. Am J Cardiol (2007) 1.01

Successful dissemination of a community-based strength training program for older adults by peer and professional leaders: the people exercising program. J Am Geriatr Soc (2008) 0.99

A geospatial analysis of emergency transport and inter-hospital transfer in ST-segment elevation myocardial infarction. Am J Cardiol (2007) 0.97

Interindividual variability and intra-individual reproducibility of glycemic index values for commercial white bread. Diabetes Care (2007) 0.96

Time-dependent predictors of primary cardiac arrest in patients with acute myocardial infarction. Am J Cardiol (2003) 0.96

Temporal trends in health-related quality of life among hemodialysis patients in the United States. Clin J Am Soc Nephrol (2009) 0.94

Passageless comprehension on the Nelson-Denny reading test: well above chance for university students. J Learn Disabil (2009) 0.91

A percutaneous coronary intervention-thrombolytic predictive instrument to assist choosing between immediate thrombolytic therapy versus delayed primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol (2008) 0.89

The impact of electrocardiographic left ventricular hypertrophy and bundle branch block on the triage and outcome of ED patients with a suspected acute coronary syndrome: a multicenter study. Am J Emerg Med (2004) 0.88

Hematocrit and left ventricular mass: the Framingham Heart study. J Am Coll Cardiol (2004) 0.88

Tissue plasminogen activator was cost-effective compared to streptokinase in only selected patients with acute myocardial infarction. J Clin Epidemiol (2004) 0.87

Forceps reduction of the syndesmosis in rotational ankle fractures: a cadaveric study. J Bone Joint Surg Am (2012) 0.85

Acute resting myocardial perfusion imaging in patients with diabetes mellitus: results from the Emergency Room Assessment of Sestamibi for Evaluation of Chest Pain (ERASE Chest Pain) trial. J Nucl Cardiol (2004) 0.84

Is the presence of medical trainees associated with increased mortality with weekend admission? BMC Med Educ (2014) 0.84

Resources and Capabilities of the Department of Veterans Affairs to Provide Timely and Accessible Care to Veterans. Rand Health Q (2016) 0.83

Tufts CTSI: comparative effectiveness research as a conceptual framework for a focus on impact. Clin Transl Sci (2010) 0.80

Clinical features, triage, and outcome of patients presenting to the ED with suspected acute coronary syndromes but without pain: a multicenter study. Am J Emerg Med (2004) 0.79

Is patient diagnosis a risk factor for organ space infection after colorectal resections? Dis Colon Rectum (2014) 0.77

Baseline characteristics predict risk of progression and response to combined medical therapy for benign prostatic hyperplasia (BPH). BJU Int (2014) 0.75

The diagnostic accuracy of symptom validity tests when used with postsecondary students with learning disabilities: a preliminary investigation. Arch Clin Neuropsychol (2009) 0.75